Changes in the Intraocular Cytokine Levels after Intravitreal Bevacizumab in Uveitic Macular Edema

REFERENCES

• Arend O, Remky A, Harris A, et al. Macular microcirculation in cystoid maculopathy of diabetic patients. Br J Ophthalmol. 1995;79(7):628–632.
   PubMed Web of Science ®Google Scholar
• Angunawela RI, Heatley CJ, Williamson TH, et al. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: long term management and outcome. Acta Ophthalmol Scand. 2005;83(5):595–599.
   PubMedGoogle Scholar
• Bae JH, Lee CS, Lee SC. Efficacy and safety of intravitrealbevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina. 2011;31(1):111–118.
   PubMed Web of Science ®Google Scholar
• Cervantes-Castañeda RA, Giuliari GP, Gallagher MJ, et al. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up. Eur J Ophthalmol. 2009;19(4):622–629.
   PubMed Web of Science ®Google Scholar
• Cordero Coma M, Sobrin L, Onal S, et al. Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology. 2007;114(8):1574–1579.
   PubMed Web of Science ®Google Scholar
• Mackensen F, Heinz C, Becker MD, et al. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina. 2008;28(1):41–45.
   PubMed Web of Science ®Google Scholar
• Weiss K, Steinbrugger I, Weger M, et al. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Eye(Lond). 2009;23(9):1812–1818.
   Google Scholar
• Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29(5):354–362.
   PubMed Web of Science ®Google Scholar
• Fine HF, Baffi J, Reed GF, et al. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol. 2001;132(5):794–796.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Kertes PJ, Eng KT, et al. Alterations in the intraocular cytokine milieu afterin travitreal bevacizumab. Invest Ophthalmol Vis Sci. 2010;51(5):2388–2392.
   PubMed Web of Science ®Google Scholar
• Lacomba MS, Martin CM, Chamond RR, et al. Aqueous and serum interferon gamma, interleukin (IL)-2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol. 2000;118(6):768–772.
   PubMedGoogle Scholar
• Ooi KG, Galatowicz G, Towler HM, et al. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFN gamma profiles in uveitis. Invest Ophthalmol Vis Sci. 2006;47(1):272–277.
   PubMed Web of Science ®Google Scholar
• Perez VL, Papaliodis GN, Chu D, et al. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm. 2004;12(3):193–201.
   PubMed Web of Science ®Google Scholar
• Valentincic NV, de Groot-Mijnes JD, Kraut A, et al. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis.2011;17:2003–2010.
   PubMed Web of Science ®Google Scholar
• Ahn JK, Yu HG, Chung H, et al. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol. 2006;142(3):429–434.
   PubMed Web of Science ®Google Scholar
• Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49(7):3058–3064.
   PubMed Web of Science ®Google Scholar
• Bian ZM, Elner SG, Elner VM. Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res. 2007;84(5):812–822.
   PubMed Web of Science ®Google Scholar
• Solà-Villà D, Camacho M, Solà R, et al. IL-1 beta inducesVEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells. Kidney Int. 2006;70(11):1935–1941.
   PubMed Web of Science ®Google Scholar
• Cha HS, Bae EK, Koh JH, et al. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol.2007;34(1):16–19.
   PubMed Web of Science ®Google Scholar
• Cohen T, Nahari D, Cerem LW, et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271(2):736–741.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Y, Feurino LW, et al. Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci. 2008;99(4):733–737.
   PubMed Web of Science ®Google Scholar
• Gulati N, Forooghian F, Lieberman R, et al. Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2011;95(2):162–165.
   PubMed Web of Science ®Google Scholar
• deSmet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. ProgRetin Eye Res. 2011;30(6):452–470.
   PubMed Web of Science ®Google Scholar
• Lutty GA, Merges C, Threlkeld AB, et al. Heterogeneity in localization of isoforms of TGF-β in human retina, vitreous and choroid. Invest Ophthalmol Vis Sci. 1993;34(3):477–487.
   PubMed Web of Science ®Google Scholar
• Kaiser CJ, Ksander BR, Streilein JW. Inhibition of lymphocyte proliferation of aqueous humor. RegImmunol. 1989;2(1):42–49.
   PubMedGoogle Scholar
• Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-b and small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 1990;144(8):3021–3027.
   PubMed Web of Science ®Google Scholar
• Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32(8):2201–2211.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Kosiewicz MM, Alard P, et al. On the mechanisms by which transforming growth factor-b2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol. 1997;27(7):1648–1656.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Alard P, Streilein JW. TGF-b promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol. 1998;160(4):1589–1597.
   PubMed Web of Science ®Google Scholar
• Ohta K, Yamagami S, Taylor AW, et al. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2000;41(9):2591–2599.
   PubMed Web of Science ®Google Scholar
• Denniston AK, Kottoor SH, Khan I, et al. Endogenous cortisol and TGF-beta in human aqueous humor contribute to ocular immune privilege by regulating dendritic cell function. J Immunol. 2011;186(1):305–311.
   PubMed Web of Science ®Google Scholar
• de Boer JH, Limpens J, Orengo-Nania S, et al. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35(10):3702–3710.
   PubMed Web of Science ®Google Scholar
• James K. Interactions between cytokines and a2-macroglobulin. Immunol Today. 1990;11(5):163–166.
   PubMedGoogle Scholar
• Andres JL, Stanley K, Cheifetz S, et al. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor- β. Cell Biol. 1989;109(6 Pt 1):3137–3145.
   PubMed Web of Science ®Google Scholar
• Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989;10(8):258–261.
   PubMedGoogle Scholar
• Nagineni CN, Samuel W, Nagineni S, et al. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol. 2003;197(3):453–462.
   PubMed Web of Science ®Google Scholar
• Khera TK, Dick AD, Nicholson LB. Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins. Prog Retin Eye Res. 2010;29(6):610–621.
   PubMed Web of Science ®Google Scholar
• Ozdamar Y, Berker N, Bahar G, et al. Inflammatory mediators and posterior segment involvement in ocular Behcet disease. Eur J Ophthalmol. 2009;19(6):998–1003.
   PubMed Web of Science ®Google Scholar
• Santos Lacomba M, Marcos Martín C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33(5):251–255.
   PubMed Web of Science ®Google Scholar
• Sugita S, Takase H, Taguchi C, et al. The role of soluble TNF receptors for TNF-alpha in uveitis. Invest Ophthalmol Vis Sci. 2007;48(7):3246–3252.
   PubMed Web of Science ®Google Scholar